Table 1. Clinical parameters and tumour characteristics for well (n = 10), moderately (Mod, n = 10) and poorly differentiated (n = 10) endometrial adenocarcinomas.
SAMPLE NO | GRADE | FIGO STAGE |
1 | Well | Ib |
2 | Well | Ib |
3 | Well | Ia |
4 | Well | Ic |
5 | Well | IIIa |
6 | Well | Ib |
7 | Well | Ib |
8 | Well | Ib |
9 | Well | Ia |
10 | Mod | Ic |
11 | Mod | Ic |
12 | Mod | Ia |
13 | Mod | Ib |
14 | Mod | IIb |
15 | Mod | Ib |
16 | Mod | Ic |
17 | Mod | IIb* |
18 | Mod | IIIa |
19 | Mod | Ib |
20 | Poor | Ia |
21 | Poor | IIIa |
22 | Poor | Ib |
23 | Poor | Ib |
24 | Poor | IIIa |
25 | Poor | Ib |
26 | Poor | Ib |
27 | Poor | IIIa |
28 | Poor | IIIa |
29 | Poor | IIb* |
All endometrial adenocarcinomas studied were of pure or predominantly of endometrioid type. There were no pure serous or clear cell subtypes in the series and none of the tumours showed carcinosarcoma.
*in these two samples myometrial invasion was <50%.